Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,832.00
Bid: 1,824.00
Ask: 1,836.00
Change: -36.00 (-1.93%)
Spread: 12.00 (0.658%)
Open: 1,868.00
High: 1,882.00
Low: 1,828.00
Prev. Close: 1,868.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

15 Sep 2009 14:32

RNS Number : 0931Z
Genus PLC
15 September 2009
 

15 September 2009

FOR IMMEDIATE RELEASE 

GENUS plc

('Genus' or 'the Company')

Directors' and PDMRs' Share Options

Genus announces that conditional nil-cost share options were granted under the Genus 2004 Performance Share Pla("the Plan") today to Richard Wood, Chief Executive, as to 68,755 ordinary shares of 10 pence each in the Company ("Shares")to John Worby, Group Finance Director, as to 42,017 Shares, to Ian Biggs, Chief Operating Officer, The Americas as to 30,558 Shares, to Thomas Philip Acton, Chief Operating Officer, Europe & Asia as to 30,558 shares, to Ian Farrelly, Group Company Secretary & General Counsel as to 22,154 shares and to David Crosby, Group Financial Controller as to 19,404 shares.

These options are subject to performance conditions which relate to growth in the Company's earnings per share over a three year period and which trigger vesting on an incremental basis.

Richard Wood's direct shareholding in the Company stands at 120,856 Shares representing 0.203% of the issued share capital of the Company that is currently 59,563,973 Shares. In addition, he is the beneficial owner of 292,465 conditional shares and nil-cost options.

John Worby's direct shareholding stands at 10,000 Shares representing 0.016% of the issued share capital of the Company. In addition, he is the beneficial owner of 128,540 nil-cost options

Ian Biggs' direct shareholding stands at 30,152 Shares representing 0.051% of the issued share capital of the Company. In addition, he is the beneficial owner of 116,490 conditional shares and nil-cost options

Thomas Philip Acton's direct shareholding stands at 37,864 Shares representing 0.064% of the issued share capital of the Company. In addition, he is the beneficial owner of 109,185 conditional shares and nil-cost options.

Ian Farrelly has no direct shareholding in the Company and is the beneficial owner of 70,277 nil-cost share options and 9,534 market value share options. 

David Crosby has no direct shareholding in the Company and is the beneficial owner of 19,404 nil-cost share options and 16,373 market value share options. 

 

For further information please contact:

 

Ian Farrelly

Group Company Secretary & General Counsel 

Genus plc  Tel: 01256 345996

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUVOORKARKAAR
Date   Source Headline
23rd Feb 20167:00 amRNSINTERIM RESULTS
1st Feb 20161:22 pmRNSBlocklisting Interim Review
4th Jan 20165:40 pmRNSTotal Voting Rights
11th Dec 20153:14 pmRNSDirector/PDMR Shareholding
9th Dec 20154:30 pmRNSDirector/PDMR Shareholding
8th Dec 20157:00 amRNSTackles major pig disease with breakthrough tech
1st Dec 20154:54 pmRNSHolding(s) in Company
1st Dec 20154:46 pmRNSTotal Voting Rights
19th Nov 20152:52 pmRNSResult of AGM
19th Nov 20157:00 amRNSAGM - TRADING UPDATE
2nd Nov 20153:04 pmRNSTotal Voting Rights
22nd Oct 20155:48 pmRNSHolding(s) in Company
21st Oct 20156:10 pmRNSDirector/PDMR Shareholding
15th Oct 201512:46 pmRNSAnnual Report and Notice of AGM
1st Oct 20153:00 pmRNSTotal Voting Rights
15th Sep 201511:00 amRNSDirector/PDMR Shareholding
8th Sep 20157:00 amRNSPreliminary Results
3rd Aug 20152:00 pmRNSBlocklisting Interim Review
30th Jun 20152:00 pmRNSTotal Voting Rights
29th Jun 20152:00 pmRNSChange of Registered Office
29th May 20152:00 pmRNSTotal Voting Rights
12th May 20157:00 amRNSCapital Markets Event and Trading Update
11th May 20152:00 pmRNSHolding(s) in Company
7th May 20152:21 pmRNSHolding(s) in Company
30th Apr 20152:00 pmRNSTotal Voting Rights
14th Apr 20152:00 pmRNSDirector/PDMR Shareholding
13th Apr 20155:06 pmRNSHolding(s) in Company
1st Apr 20157:00 amRNSCompletion of acquisition
31st Mar 20154:04 pmRNSTotal Voting Rights
19th Mar 20155:46 pmRNSDirector/PDMR Shareholding
12th Mar 20152:09 pmRNSDirector/PDMR Shareholding
9th Mar 20151:24 pmRNSDirector Declaration
27th Feb 20152:00 pmRNSTotal Voting Rights
24th Feb 201511:00 amRNSHolding(s) in Company
24th Feb 20157:00 amRNSInterim Results
16th Feb 20157:00 amRNSAcquisition of 51% of In Vitro Brasil
2nd Feb 20151:22 pmRNSBlock Listing Six Monthly Return
31st Dec 201412:01 pmRNSTotal Voting Rights
12th Dec 201410:44 amRNSDirector/PDMR Shareholding
1st Dec 20144:36 pmRNSTotal Voting Rights
21st Nov 20144:03 pmRNSDirector/PDMR Shareholding
14th Nov 20143:42 pmRNSResult of AGM
14th Nov 20147:00 amRNSTrading Update
31st Oct 201412:20 pmRNSTotal Voting Rights
22nd Oct 20149:29 amRNSDirector/PDMR Shareholding
10th Oct 20145:58 pmRNSHolding(s) in Company
8th Oct 20143:47 pmRNSAnnual Report and Annual General Meeting
3rd Sep 20147:00 amRNSPreliminary Results
3rd Sep 20147:00 amRNSPorcine Multiplication Agreement in China
29th Aug 20143:08 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.